Use of the EIP for the administration of the following drugs is considered medically necessary for selected patients on:
morphine and other parenteral analgesics for treatment of severe, chronic cancer pain that is resistant to conventional therapy. Acceptable routes are subcutaneous (SC) andintravenous (IV);
insulin for treatment of insulin-dependent diabetes mellitus in patients who cannot be controlled by intermittent dosing. Acceptable routes are SC and IV;
heparin for treatment of severe thromboembolic disease that cannot be managed conventionally(e.g., complicated pregnancy). Acceptable routes are SC and IV;
chemotherapeutics for treatment of cancer. Acceptable routes are stipulated in the drug labelingand might include either IV or intra-arterial (IA).
